Longyan City First Hospital
11
4
5
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
27%
3 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Posterior Extra-fascial RARP in Intermediate or High Risk Prostate Cancer
Role: collaborator
Safety and Efficacy of Stereotactic Aspiration Plus Urokinase in Deep Intracerebral Hemorrhage Evacuation
Role: collaborator
Two Regimens of IVIG in the Treatment of Newly Diagnosed ITP in Children
Role: collaborator
Short-course High-dose Prednisone and Dexamethasone in Children With ITP
Role: collaborator
A Cohort Study on the Safety of Laparoscopic Resection of 5cm or Larger Gastric Gastrointestinal Stromal Tumors
Role: collaborator
CONVERT: Neoadjuvant Chemotherapy Alone Versus Preoperative Chemoradiation for Locally Advanced Rectal Cancer Patients
Role: collaborator
Study on Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Advanced Gastric Cancer
Role: collaborator
Multicentre REtrospective StuDy of Treatment and OUtComes in STEMI Patients in Fujian Province
Role: collaborator
REduction of rIsk for Contrast Induced Nephropathy
Role: collaborator
Triple-branch Stent Graft Placement and Total-arch Replacement for the Treatment of Acute DeBakey I Aortic Dissection
Role: collaborator
Clinical Trial of Pulmonary Cryptococcosis in China
Role: collaborator
All 11 trials loaded